Articles tagged with Antibiotic Resistance
An observational study found that human contact was responsible for 90% of the spread of one species of antibiotic-resistant bacteria to new patients. However, the same level of transmission was not seen with another species, highlighting the need for multiple prevention strategies.
Researchers at North Carolina State University discovered a gene that makes Salmonella resistant to colistin, the drug of last resort for treating multidrug-resistant infections. The mcr-3.1 gene was found in a human patient who had traveled to China two weeks prior to becoming ill with a Salmonella infection.
A systematic review of government policies aimed at reducing human antimicrobial use identified 17 types of interventions, but most were not rigorously evaluated. The authors recommend that governments ensure AMR policy interventions are tested using rigorous study designs to avoid future waste of public resources.
Scientists explore the emergence of novel genes and functional proteins from random DNA sequences, revealing peptides that confer high resistance to aminoglycosides. The study demonstrates how de novo evolution can be studied experimentally in the laboratory.
Researchers discovered a new class of antibiotics produced by the microbiome that kill bacteria by disrupting their energy metabolism. Fibupeptides, such as lugdunin, have shown promise in treating multidrug-resistant infections, including those caused by MRSA.
Researchers at Stellenbosch University studied how Mycobacterium tuberculosis develops resistance to bedaquiline, a new anti-TB drug. The study found that resistance can emerge despite adherence to the standard treatment regimen, highlighting the need for improved monitoring and diagnostic tools.
Researchers at Swansea University have found that Manuka honey is effective in killing antimicrobial resistant bacteria by 39%, improving the activity of some antibiotics. This could provide an alternative treatment for cystic fibrosis patients struggling with deadly, antibiotic-resistant respiratory infections.
A new study has helped develop a treatment option for multi-drug resistant (MDR) infections, including complicated urinary tract infections. The treatment, tebipenem pivoxil hydrobromide, is an oral antibiotic agent that may facilitate earlier discharge from hospital or treat complex infections in the community.
Scientists at the University of Sheffield have discovered a new compound that kills antibiotic-resistant gram-negative bacteria, including E. coli. The compound's unique properties make it difficult for resistance to emerge in the bacteria, paving the way for new treatment options.
Researchers observe DNA transmission between resistant and sensitive Escherichia coli bacteria, discovering a generalist efflux pump facilitating minimal protein synthesis activity. This study opens new avenues for understanding bacterial resistance mechanisms and potential therapeutic applications.
Researchers discovered that previously drug-sensitive bacteria can survive exposure to antibiotics long enough to express resistance genes, rendering them immune. The mechanisms underlying this process involve a drug-jettisoning pump and horizontal gene transfer mechanisms like bacterial conjugation.
A new modeling study suggests that rapid tests for drug-resistant infections could turn the tables against bacteria, allowing doctors to target resistant strains with precision. However, the researchers found that asymptomatic carriers must also be screened and treated to reverse the spread of resistance.
A leading scientist proposes five rules to tackle antibiotic resistance, including protecting new drugs and using diverse antimicrobials. The World Health Organisation warns of a post-antibiotic era, and the study aims to provide a roadmap for integrated microbial management.
BioBits Health, a Northwestern University-led project, introduces CRISPR and antibiotic resistance to high school students. Students perform experiments using freeze-dried cell-free reactions, visualizing DNA editing and drug resistance, and exploring ethics.
A new compound, C10, was discovered to increase the effectiveness of frontline antibiotic isoniazid against Mycobacterium tuberculosis (Mtb), a deadly disease. The study suggests that antibiotic resistance in Mtb may be reversible.
A new drug combination of gentamicin and azithromycin shows promising results in treating treatment-resistant gonorrhoea, with a cure rate of 91% compared to 98% for the current ceftriaxone treatment. The study suggests that gentamicin could be used as an alternative for patients who are allergic or intolerant to ceftriaxone.
A team of scientists, led by microbiologist Marjon de Vos, conducted a review to explore the application of evolutionary theory in clinical microbiology. By analyzing microbial communities and genetic data, they identified potential solutions for treating cystic fibrosis patients and limiting the spread of antibiotic resistance.
Researchers found that a 'superbug' clone of E. coli called ST131 has evolved to prevent itself from becoming the sole dominant clone, allowing it to colonize the human gut more competitively than other strains. The discovery provides insight into how this process happens and may help develop strategies to prevent it.
Researchers analyzed over 850 drug-resistant E. coli genomes to identify survival strategies, finding that clones use niche separation and NFDS to evolve and succeed in the host environment. The study's findings highlight the importance of understanding bacterial ecology to develop effective prevention methods.
Researchers developed a drug resistance index to track global trends in antibiotic therapy effectiveness. The study found that high-income countries generally have lower rates of resistance, while low- and middle-income countries face greater challenges due to limited access to newer drugs.
Researchers discovered a gene that enables bacteria to resist linezolid in cats and dogs at a UK animal hospital, suggesting potential transmission between animals and humans.
Scientists have created a genetically engineered bacterium that can specifically kill multiple antibiotic-resistant bacteria without harming beneficial bacteria. The novel tool, based on the CRISPR-Cas9 system, has shown a minimal rate of emergence of new resistance and has potential applications in treating infectious diseases.
A study of 230 travelers found that staying in hotels increases the risk of contracting multi-drug resistant bacteria by four times. Younger travelers aged 20-30 are particularly at risk, and people visiting certain regions face a higher risk of infection with ESBL-producing Enterobacteriaceae.
A European study finds associations between antibiotic resistance and seasonal temperature, with significant contributions to MRSA variance. Climate change may increase AMR transmission, particularly carbapenem resistance, in various healthcare systems.
A UK study found that only one-third of patients with suspected urinary tract infections (UTIs) actually have evidence of the infection. In reality, nearly all patients receive antibiotics, which contributes to antimicrobial resistance. The study suggests implementing antimicrobial stewardship initiatives could reduce unnecessary antib...
A cluster of four NYC hospital patients harboring highly resistant E. coli with the MCR-1 gene were identified, highlighting the risk of spread and need for ongoing surveillance of this rare antibiotic resistance gene.
Researchers at the University of Washington tested the impact of water disinfection methods on antibiotic resistance genes. Three disinfectant methods showed greater than 90% degradation or deactivation, while two others had little to no effect.
A novel technology developed by Professor Douglas Kell uses flow cytometry to detect and count individual bacteria in urine samples. This allows doctors to determine the most effective antibiotic for treating specific bacterial infections, potentially reducing the reliance on last-resort antibiotics.
Scientists found that certain antibiotics trigger the generation of toxic molecules called reactive oxygen species (ROS), which can lead to new mutations and antibiotic resistance. ROS-reducing drugs like edaravone can prevent these mutations, suggesting a potential new strategy to combat resistance evolution
Researchers discover how bacteria evolve mutations that confer antibiotic resistance and find a way to inhibit this process with FDA-approved drug edaravone. The study reveals that low doses of ciprofloxacin induce DNA breaks, leading to mutations in bacterial populations.
A research team led by Natalia Korotkova has identified a potential target for developing a vaccine against Group A Streptococcus, which causes strep throat and other serious infections. The gacH gene, which enables the bacteria to reinforce its resistance to the immune system, is a promising candidate for vaccine design.
An international study found that wastewater treatment plants in seven European countries have varying levels of antibiotic resistance, with southern Europe showing higher rates. The study suggests that modern treatment plants are effective in removing resistant bacteria, but older or poorly managed plants may contribute to the problem.
Research finds that high levels of hygiene promote resistance to antibiotics, with microbiome diversity decreasing in areas with strict controls. Regular measures such as airing, houseplants, and reducing antibacterial cleaning agents may counteract this trend.
A comprehensive analysis of sewage from 74 cities in 60 countries has yielded comparable global data on antimicrobial resistant bacteria. The study found that North America, Western Europe, Australia, and New Zealand have low levels of antimicrobial resistance, while Asia, Africa, and South America have high levels.
Researchers found that even low concentrations of single antibiotics lead to resistance in multiple classes. The team believes alterations in treatment processes can reduce the spread of antibiotic-resistant organisms.
The ABATE Infection Trial found that daily antiseptic bathing with nasal ointment reduced hospital-acquired bloodstream infections by 30% in patients with central venous catheters, a high-risk group. This intervention also decreased antibiotic-resistant organisms, including MRSA and vancomycin-resistant enterococcus, in this patient po...
New study finds that within two to three years after first infection, Pseudomonas aeruginosa bacteria adapt rapidly, growing slower and optimizing fitness to survive. Clinicians can monitor bacterial traits such as attachment to surfaces and aggregation in biofilms to detect early chronic infections.
The new rapid genetic test detects the Macrolide efflux gene A, which causes resistance to erythromycin and azithromycin. The test works as accurately as culture-based methods but gives results in minutes, improving point-of-care diagnostics and potentially leading to better outcomes.
A study by Bocconi University found that a new sanitation system reduced healthcare-associated infections by 52% and drug consumption by 60.3%, resulting in a 75.4% decrease in related costs. The system, which uses ecologically sustainable probiotic-based detergents, also led to an 83% decrease in detected pathogens on hospital surfaces.
Resistance to azithromycin and ceftriaxone remains a significant threat, with only limited alternatives left for successful treatment. The European Centre for Disease Prevention and Control monitors the effectiveness of recommended antibiotics through its surveillance programme.
A billion different ways for C-diff to become resistant to metronidazole have been identified. Genetic changes linked to heme levels are thought to be a key factor contributing to this resistance. Researchers are now working to identify new drug targets to combat the growing threat of C-diff, a bacterium that causes diarrhea and colitis.
The European Union's antimicrobial resistance report reveals that antimicrobials used to treat diseases transmitted between animals and humans are becoming less effective. Antimicrobial resistance has increased in Campylobacter and Salmonella bacteria, making it difficult to treat severe cases.
Scientists at DTU have discovered that a combination of mecillinam and cefotaxime can eliminate multi-drug resistant E. coli causing urinary tract infections. This novel approach could become an effective measure against antibiotic resistance, offering new hope in treating this common infection.
Researchers have discovered a way to block the VCC-1 enzyme, which disables a new antibiotic resistance gene found in benign Vibrio cholerae strains. The discovery uses Avibactam, a US FDA-approved combination drug, to effectively combat the resistant bacteria.
Researchers at McMaster University have identified a simple mechanism used by bacteria to resist antibiotics. By understanding this mechanism, scientists can design better drugs to fight infection. The study found that when bacteria become resistant, their membrane becomes more rigid and harder for the drug to penetrate.
Researchers found that antibiotic resistance genes are transferred between bacteria through viruses and transposons, leading to a fast distribution of resistance genes. This challenges the long-held assumption that only plasmids facilitate gene exchange.
A large study found that multidrug-resistant tuberculosis can be cured in conflict-affected communities using molecular diagnostics, shorter treatment periods, and socioeconomic incentives. The new approach led to a 83% cure rate compared to 74% for conventional therapy.
Researchers at Uppsala University and Emory University found that over a quarter of bacteria exhibit heteroresistance, making antibiotic treatment ineffective. The underlying genetic mechanism is often the spontaneous occurrence of gene amplifications, which can make it difficult to detect and study.
A University of Kansas geologist's work in the remote High Arctic has exposed the global spread of antibiotic-resistant microbes, including multidrug-resistant 'superbugs'. Researchers found 131 antibiotic-resistant genes in Svalbard soil samples, with some tracing back to human sewage or bird guano.
The Bitsliced Genomic Signature Index (BIGSI) allows researchers to identify antibiotic resistance genes and mutations in real time, making vast amounts of genomic data discoverable. This enables the study of disease dynamics, understanding of bacterial ancestry, and prediction of drug resistance.
A new method, developed by Case Western Reserve University researchers, identifies effective second-line antibiotics for treating germs resistant to first-line antibiotics. The approach could help clinicians choose the best treatment for patients and overcome antibiotic resistance.
A new study has confirmed the presence of a superbug gene in the Kongsfjorden region of Svalbard, one of the last pristine places on Earth. The blaNDM-1 gene, originally found in urban India, has been detected in Arctic soils and is associated with increased antibiotic resistance.
Researchers developed a rapid whole genome sequencing method that can identify specific antibiotic-resistant bacteria strains in under a day, reducing treatment time by at least 20 hours. The technology has the potential to speed personalized treatment of drug-resistant infections, which claim thousands of lives annually.
A recent study published in Nature Communications reveals a strong correlation between
A team of RCSI researchers has developed a new treatment for tuberculosis (TB) that could be used to treat hundreds of thousands of patients. The treatment uses all-trans retinoic acid, which has shown promise in previous studies and can help reduce bacteria and lung damage.
C-Path and TGen will develop a framework enabling state institutions to respond to antimicrobial resistance with a genomic surveillance system. The Prevent HAARM system aims to monitor and track antimicrobial resistant pathogens, providing rapid feedback to clinicians and public health professionals.
A new study identified a unique strain of CA-MRSA driving antimicrobial resistance and spread, particularly in vulnerable populations. Genomic surveillance played a crucial role in tracking the outbreak and informing infection control strategies.
Researchers have discovered a previously unknown strain of bacteria in ancient Irish soil that effectively inhibits the growth of four top-six multi-resistant pathogens. The strain, Streptomyces sp. myrophorea, has shown promise against gram-positive and gram-negative bacteria, providing new hope for combating antibiotic resistance.
A large study found that widespread, low-intensity antibiotic use in the US is more closely linked to antibiotic resistance than high-intensity use by a small fraction of the population. The study analyzed data from over 60 million Americans and found that occasional use was associated with higher rates of resistance.
Researchers created a predictive model to identify inhibitors of the multi-drug resistance associated protein-2 efflux transporter, achieving prediction accuracy of up to 0.79. The support vector machine model built on selected features showed the best performance.